-
Mashup Score: 2CE Education - 2 year(s) ago
Release Date: December 8, 2021Expiration Date: December 8, 2022Expected time to complete this activity as designed: 30 minutes There are no fees for participating in or receiving credit for this online activity. Program Overview Join Dr. Kolb as he reviews secondary AML treatment options for pediatric patients. Topics include molecular aberrations in childhood AML, limitations of current…
Source: managingaml.comCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 2Why is it important to repeat genomic analysis at the time of AML relapse and what mutation should be tested? - 2 year(s) ago
Nicholas J. Short, MD Assistant ProfessorDepartment of LeukemiaDivision of Cancer MedicineThe University of Texas MD Anderson Cancer CenterHouston, Texas Welcome to Managing AML. My name is Dr. Nicholas Short and I’m frequently asked, “Why is it important to repeat genomic analysis at the time of AML relapse and what mutation should be…
Source: managingaml.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
RT @medical_medicom: 🤔What does secondary acute myeloid leukemia mean 4⃣ kids❓ SHORT VIDEO➡️https://t.co/YUpxyypEtI #medtwitter #onctwitter…